Cargando…

Metronomic Therapy in Oral Squamous Cell Carcinoma

Metronomic therapy is characterized by drug administration in a low-dose, repeated, and regular manner without prolonged drug-free interval. The two main anticancer mechanisms of metronomic therapy are antiangiogenesis and immunomodulation, which have been demonstrated in several delicate in vitro a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Su, Nai-Wen, Chen, Yu-Jen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8269021/ https://www.ncbi.nlm.nih.gov/pubmed/34206730 http://dx.doi.org/10.3390/jcm10132818

Ejemplares similares

Metronomic Cordycepin Therapy Prolongs Survival of Oral Cancer-Bearing Mice and Inhibits Epithelial-Mesenchymal Transition
por: Su, Nai-Wen, et al.
Publicado: (2017)

Oral metronomic chemotherapy as a feasible preoperative therapy in advanced resectable oral cavity squamous cell carcinomas— a preliminary experience
por: Shenoy, V P Praveen Kumar, et al.
Publicado: (2022)

The Spectrum of Histomorphological Changes and Pathological Tumor Response following Preoperative Oral Metronomic Chemotherapy in Oral Squamous Cell Carcinoma
por: Aravind, Sithara, et al.
Publicado: (2022)

Oral tegafur-uracil as metronomic therapy following intravenous FOLFOX for stage III colon cancer
por: Huang, Wen-Yen, et al.
Publicado: (2017)

Metronomics for thymic carcinoma
por: del Toro, Jacobo Muñoz, et al.
Publicado: (2014)

Metronomic Chemotherapy
por: Cazzaniga, Marina Elena, et al.
Publicado: (2021)

Metronomic chemotherapy
por: Maiti, Rituparna
Publicado: (2014)

Efficacy and safety of neoadjuvant chemotherapy (NACT) with paclitaxel plus carboplatin and oral metronomic chemotherapy (OMCT) in patients with technically unresectable oral squamous cell carcinoma (OSCC)
por: Kashyap1, Lakhan, et al.
Publicado: (2021)

Metastatic Primary Duodenal Adeno-Carcinoma Responding to Metronomic Oral Cyclophosphamide Chemotherapy
por: Bandyopadhyay, Anis, et al.
Publicado: (2014)

Metronomic Chemotherapy in Prostate Cancer
por: Wysocki, Piotr J., et al.
Publicado: (2022)

Metronomic Anti-Cancer Therapy: A Multimodal Therapy Governed by the Tumor Microenvironment
por: Muñoz, Raquel, et al.
Publicado: (2021)

Progress of Nanomaterials-Based Photothermal Therapy for Oral Squamous Cell Carcinoma
por: Niu, Qin, et al.
Publicado: (2022)

Head and neck cancer: metronomic chemotherapy
por: De Felice, Francesca, et al.
Publicado: (2015)

Roles of Mitochondria in Oral Squamous Cell Carcinoma Therapy: Friend or Foe?
por: Bai, Junqiang, et al.
Publicado: (2022)

Bevacizumab and oral metronomic cyclophosphamide in platinum-resistant ovarian cancer
por: Pujade-Lauraine, Eric
Publicado: (2013)

Anti-Angiogenic Effect of Orally Available Pemetrexed for Metronomic Chemotherapy
por: Maharjan, Ruby, et al.
Publicado: (2019)

Metronomic Chemotherapy for Palliative Treatment of Malignant Oral Tumors in Dogs
por: Milevoj, Nina, et al.
Publicado: (2022)

The Overall Efficacy and Outcomes of Metronomic Tegafur-Uracil Chemotherapy on Locally Advanced Head and Neck Squamous Cell Carcinoma: A Real-World Cohort Experience
por: Yeh, Tsung-Jang, et al.
Publicado: (2021)

All-oral metronomic DEVEC schedule in elderly patients with peripheral T cell lymphoma
por: Cox, Maria Christina, et al.
Publicado: (2020)

Low‐dose metronomic chemotherapy improves tumor control in nasopharyngeal carcinoma
por: Chen, Yu‐Pei, et al.
Publicado: (2022)

Circular RNA Expression in Oral Squamous Cell Carcinoma
por: Wang, Yu-Fan, et al.
Publicado: (2018)

Metronomic photodynamic therapy using an implantable LED device and orally administered 5-aminolevulinic acid
por: Kirino, Izumi, et al.
Publicado: (2020)

MAPK Signaling Pathway in Oral Squamous Cell Carcinoma: Biological Function and Targeted Therapy
por: Cheng, Yuxi, et al.
Publicado: (2022)

Metronomic temozolomide as second line treatment for metastatic poorly differentiated pancreatic neuroendocrine carcinoma
por: De Divitiis, C., et al.
Publicado: (2016)

Epigenetics in oral squamous cell carcinoma
por: Hema, K N, et al.
Publicado: (2017)

The Role of the Oral Microbiota in the Etiopathogenesis of Oral Squamous Cell Carcinoma
por: Vyhnalova, Tereza, et al.
Publicado: (2021)

Role of Oral Bacteria in the Development of Oral Squamous Cell Carcinoma
por: Li, Qinyang, et al.
Publicado: (2020)

Role of viruses in oral squamous cell carcinoma
por: Metgud, Rashmi, et al.
Publicado: (2012)

Endoplasmic Reticulum Stress of Oral Squamous Cell Carcinoma Induces Immunosuppression of Neutrophils
por: Wu, Ching-Fang, et al.
Publicado: (2022)

Metronomic chemotherapy prevents therapy-induced stromal activation and induction of tumor-initiating cells
por: Chan, Tze-Sian, et al.
Publicado: (2016)

Efficacy and safety of oral metronomic etoposide in adult patients with metastatic osteosarcoma
por: Perret, Audrey, et al.
Publicado: (2020)

The Immune Cells in the Development of Oral Squamous Cell Carcinoma
por: Caponio, Vito Carlo Alberto, et al.
Publicado: (2023)

Metronomic therapy with oral 6-mercaptopurine in elderly acute myeloid leukemia: A prospective pilot study
por: Kapoor, Akhil, et al.
Publicado: (2016)

MicroRNAs in Head and Neck Squamous Cell Carcinoma (HNSCC) and Oral Squamous Cell Carcinoma (OSCC)
por: Shiiba, Masashi, et al.
Publicado: (2010)

Metronomic Celecoxib Therapy in Clinically Available Dosage Ablates Hepatocellular Carcinoma via Suppressing Cell Invasion, Growth, and Stemness in Pre-Clinical Models
por: Yeh, Chun-Chieh, et al.
Publicado: (2020)

Metronomic chemotherapy with cyclophosphamide and dexamethasone in patients with metastatic carcinoma of the prostate
por: Dickinson, P D, et al.
Publicado: (2012)

Can metronomic chemotherapy be an alternative to sorafenib in advanced hepatocellular carcinoma?
por: Kim, Do Young
Publicado: (2017)

Durable effect of imatinib and metronomic chemotherapy with capecitabine in pancreatic carcinoma
por: Al-Sukhun, Sana, et al.
Publicado: (2023)

A Combination of Immune Checkpoint Inhibition with Metronomic Chemotherapy as a Way of Targeting Therapy-Resistant Cancer Cells
por: Kareva, Irina
Publicado: (2017)

Overview of immunology of oral squamous cell carcinoma
por: Sathiyasekar, Anisha Cynthia, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_32v39akcvlmeqj97i0jd0ag8sa